Pharmacologic modulation of splanchnic blood flow

Current Opinion in Critical Care

Volumn 4, Issue 2, 1998, Pages 104-110

  De Backer, Daniel ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0008433643     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199804000-00007     Document Type: Article

References (107)

1. Fong Y, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, Allison AC, Cerami A, Shires GT, Lowri SF: The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 1990, 85:1896-1904.
2. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988, 123:1459-1464.
3. 2+ whereas liver glucose uptake (measured by stable isotopes) decreased.
4. Meier-Hellmann A, Specht M, Hannemann L, Hassel H, Bredle DL, Reinhart K: Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med 1996, 22:1354-1359.
5. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997, 23:282-287. In this randomized study, patients treated with epinephrine, as compared with patients treated with norepinephrine, experienced a transient decrease in pHi and a transient increase in lactate levels.
6. Reinelt H, Radermacher P, Fischer G, Geisser W, Trunk E, Wiedeck H, Mezödy M, Georgieff M, Vogt J: Dobutamine and dopexamine and the splanchnic metabolic response in septic shock. Clin Intens Care 1997, 8:38-41.
7. 2 clearance and microsphere estimate of mucosal blood flow. Am J Physiol 1985, 249:G221-G227.
8. Sair M, Winlove CP, Evans TW: Microcirculation in sepsis: experimental methods and pathophysiotogical observations. Clin Sci 1996, 90:173-182.
9. Struijker-Boudier HAJ, Crijns FRL, Van Essen H: Assessment of the microcirculation in cardiovascular disease. Clin Sci 1996, 91:131-139.
10. Casadevall M, Panés J, Piqué JM, Rodes J: Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. J Appl Physiol 1992, 263:G810-G815.
11. Aranow JS, Fink MP: Determinants of intestinal barrier failure in critical illness. Br J Anaesth 1996, 77:71-81.
12. Groeneveld ABJ, Kolkman JJ: Splanchnic tonometry: a review of physiology, methodology and clinical applications. J Crit Care 1994, 9:198-210.
13. Grum CG: Tissue oxygenation in low flow states and during hypoxemia. Crit Care Med 1993, 21:S44-S49.
14. Dantzker DR: Adequacy of tissue oxygenation. Crit Care Med 1993, 21:S40-S43.
15. Fink MP: Adequacy of gut oxygenation in endotoxemia and sepsis. Clin Care Med 1993, 21:S4-S8.
16. Creteur J, De Backer D, Vincent JL: Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validations studies. Anesthesiology 1997, 87:504-510.
17. Kvietys PR, Granger DN: Vasoactive agents and splanchnic oxygen uptake. Am J Physiol 1982, 243:G1-G9.
18. Braatvedt GD, Flynn MD, Stanners A, Halliwell M, Corrall RJM: Splanchnic blood flow in man: evidence for mediation via a b-adrenergic mechanism. Clin Sci 1993, 84:201-207.
19. Winsö O, Biber B, Martner J: Does dopamine suppress stress-induced intestinal and renal vasoconstriction? Acta Anaesthesiol Scand 1995, 29:508-514.
20. Robie NW, Goldberg LI: Comparative systemic and regional hemodynamic effects of dopamine and dobutamine. Am Heart J 1975, 90:340-345.
21. Giraud GD, Mac Cannell KL: Decreased nutrient blood flow during dopamine and epinephrine induced intestinal vasodilation. J Pharmacol Exp Ther 1984, 230:214-220.
22. Johnson DJ, Johannigman JA, Branson RD, Davis K, Hurst JM: The effect of low dose dopamine on gut hemodynamics during PEEP ventilation for acute lung injury. J Surg Res 1991, 50:344-349.
23. Schmidt H, Secchi A, Wellmann R, Böhrer H, Bach A, Martin E: Effect of low-dose dopamine on intestinal villus microcirculation during normotensive endotoxemia in rats. Br J Anaesth 1996, 76:707-712.
24. Pearson RJ, Barrington KJ, Jirsch DW, Cheung PY: Dopaminergic receptor-mediated effects in the mesenteric vasculature and renal vasculature of the chronically instrumented newborn piglet Crit Care Med 1996, 24:1706-1712.
25. 2 (determined by the "Erlangen microphotometer"), whereas dobuta-mine had no effect.
26. 2 estimated by the Erlangen microphotometer.
27. Steinberg S, Azar G, Love R, Lee R, Choe E, Flint L: Dopexamine prevents depression of mesenteric blood flow caused by positive end-expiratory pressure in rats. Surgery 1996, 120:597-602.
28. Breslow MJ, Miller CF, Parker SD, Walman AT, Traystman RJ: Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 1987, 252:H291-H300.
29. Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ: The effects of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 1992, 112:549-561.
30. Cheung PY, Barrington KJ, Pearson RJ, Bigam DL, Finer NN, Van Aerde JE: Systemic, pulmonary and mesenteric perfusion and oxygenation effects of dopamine and epinephrine. Am J Respir Crit Care Med 1997, 155:32-37. Experimental study in piglets: dopamine (up to 32 μg/kg/min) did not alter portal vein and hepatic artery despite a significant increase in cardiac output. Epinephrine did not alter these parameters at low dose (0.2 μg/kg/min) and decreased it at high dose (3.2 μg/kg/min).
31. Azar G, Love R, Choe E, Flint L, Steinberg S: Neither dopamine nor dobutamine reverses the depression in mesenteric blood flow caused by positive end-expiratory pressure. J Trauma 1996, 40:679-687.
32. Royblat L, Gelman S, Bradley EL, Henderson T, Parks D: Dopamine and hepatic oxygen supply-demand relationship. Can J Physiol Pharmacol 1989, 68:1165-1169.
33. Segal JM, Phang PT, Walley KR: Low-dose dopamine hastens onset of gut ichemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992, 73:1159-1164.
34. Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21:1296-1303.
35. Meier-Hellmann A, Reinhart K: Effects of catecholamines on regional perfusion and oxygenation in critically ill patients. Acta Anaesthesiol Scand 1995, 39:239-248.
36. Gardeback M, Settergren G, Ohquist G, Tiren C: Effect of dopexamine on calculated low gastric intramucosal pH following valve replacement. Acta Anaesthesiol Scand 1995, 39:599-604.
37. Gardeback M, Settergren G: Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary bypass. Acta Anaesthesiol Scand 1995, 39:1066-1070.
38. Sinclair DG, Houldsworth PE, Keogh B, Pepper J, Evans TW: Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intensive Care Med 1997, 23:510-516.
39. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC: Increasing splanchnic blood flow in the critically ill. Chest 1995, 108:1648-1654.
40. Nevière R, Mathieu D, Chagnon JL, Lebleu N, Wattel F: The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996, 154:1684-1688. In this randomized crossover study, dopamine (5 μg/kg/min) decreased and dobutamine (5 μg/kg/min) increased gastric mucosal blood flow.
41. Olson D, Pohlman A, Hall JB: Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance. Am J Respir Crit Care Med 1996, 154:1664-1670. In this randomized study, dopamine at low dose did not alter pHi.
42. Meier-Hellmann A, Bredle DL, Specht M, Spies C, Hannemann L, Reinhart K: The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997, 23:31-37. The administration of dopamine at low dose increased hepatosplanchnic blood flow in patients with baseline fractional splanchnic blood flow lower than 30% but not in the other patients. pHi remained unchanged in both groups.
43. Marik PE, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994, 272:1354-1357.
44. Tighe D, Moss R, Haywood G, Webb A, Al-Saadi N, Heath F, Bennett D: Dopexamine hydrochloride maintains portal blood flow and attenuates hepatic ultrastructural changes in a porcine peritonitis model of multiple system organ failure. Circ Shock 1993, 39:199-206.
45. Schmidt H, Secchi A, Wellmann R, Bach A, Böhrer H, Martin E: Dopexamine maintains intestinal villus blood flow during endotoxemia in rats. Crit Care Med 1996, 24:1233-1237.
46. Lund N, De Asia RJ, Cladis F, Papadakos PJ, Thorborg PAJ: Dopexamine hydrochloride in septic shock: effects on oxygen delivery and oxygenation of gut, liver and muscle. J Trauma 1995, 38:767-775.
47. Cain SM, Curtis SE: Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 1991, 19:1552-1560.
48. Uusaro A, Ruokonen E, Takala J: Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995, 74:149-154.
49. Leier CV: Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 1988, 62:86E-93E.
50. Smithies M, Yee TH, Jackson L, Beale R, Bihari D: Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 1994, 22:789-795.
51. Berendes E, Möllhoff T, Van Aken H, Schmidt C, Erren M, Deng MC, Weynand M, Loick HM: Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg 1997, 84:950-957.
52. Trinder TJ, Lavery GG, Fee JPH, Lowry KG: Correction of splanchnic oxygen deficit in the intensive care unit: dopexamine and colloid versus placebo. Anaesth Intens Care 1995, 23:178-182.
53. Drexler H, Höing S, Faude F, Wollschläger H, Just H: Central and regional vascular hemodynamics following intravenous milrinone in the conscious rat: comparison with dobutamine. J Cardiovasc Pharmacol 1987, 9:563-569.
54. Liang CS, Yi JM, Sherman LG, Black J, Gavras H, Hood WB: Dobutamine infusion in conscious dogs with and without acute myocardial infarction: effects on systemic hemodynamics, myocardial blood flow and infarct size. Circ Res 1981, 49:170-180.
55. Wanless RB, Anand IS, Gurden J, Harris P, Poole-Wilson PA: Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987, 243:1101-1106.
56. Fink MP, Kaups KL, Wang H, Rothschild HR: Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery 1991, 110:154-161.
57. De Backer D, Zhang H, Manikis P, Vincent JL: Regional effects of dobutamine in endotoxic shock. J Surg Res 1996, 65:93-100.
58. Nevière R, Chagnon JL, Vallet B, Lebleu N, Marechal X, Mathieu D, Wattel F, Dupuis B: Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med 1997, 25:1371-1377. In a dog model of endotoxic shock, dobutamine (5 μg/kg/min) increased gastric and ileal mucosal blood flows and limited the decrease in pHi.
59. Secchi A, Wellmann R, Martin E, Schmidt H: Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat J Crit Care 1997, 12:137-141.
60. Ruokonen E, Takala J, Kari A: Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Crit Care Med 1993, 21:1304-1311.
61. Uusaro A, Ruokonen E, Takala J: Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995, 30:106-112.
62. Parviainen I, Ruokonen E, Takala J: Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery. Br J Anaesth 1995, 74:277-282.
63. Uusaro A, Ruokonen E, Takala J: Splanchnic oxygen transport after cardiac surgery: evidence for inadequate tissue perfusion after stabilization of hemodynamics. Intensive Care Med 1996, 22:26-33.
64. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997, 25:399-404. Hepatosplanchnic blood flow and pHi decreased when the catecholamine regimen was changed from a combination of dobutamine and norepinephrine to epinephrine in eight patients.
65. Ruokonen E, Uusaro A, Alhava E, Takala J: The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis. Intensive Care Med 1997, 23:732-737.
66. Karzai W, Lötte A, Günnicker M, Vorgrimler-Karzai UM, Priebe HJ: Dobutamine increases oxygen consumption during constant flow cardiopulmonary bypass. Br J Anaesth 1996, 76:5-8.
67. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C: Effects of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994, 150:324-329.
68. Silverman H, Tuma P: Gastric tonometry in patients with sepsis: Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992, 102:184-188.
69. Esen F, Telci L, Cakar N, Tütüncü A, Kesecioglu J, Akpir K: Evaluation of gastric intramucosal pH measurements with tissue oxygenation indices in patients with severe sepsis. Clin Intens Care 1996, 7:180-189.
70. Radermacher P, Buhl R, Santak B, Klein M, Kniemeyer HW, Becker H, Tarnow J: The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med 1995, 21:414-421.
71. Richardson PDI, Granger DN, Kvietys PR: Effects of norepinephrine, vasopressin, isoproterenol, and histamine on blood flow, oxygen uptake, and capillary filtration coefficient in the colon of the anesthetized dog. Gastroenterohgy 1980, 78:1537-1544.
72. Ryan AJ, Gisolfi CV: Responses of rat mesenteric arteries to norepinephrine during to heat stress and acidosis. J Appl Physiol 1995, 78:38-45.
73. Hussain SNA, Rutledge F, Roussos C, Magder S: Effects of norepinephrine and fluid administration on the selective blood flow distribution in endotoxic shock. J Crit Care 1988, 1:32-42.
74. Kvietys PR, Perry MA, Granger DN: Intestinal capillary exchange capacity and oxygen delivery-to-demand ratio. Am J Physiol 1983, 245:G635-G640.
75. Galindo A: Hepatic circulation and hepatic function during anesthesia and surgery. Can Anaesth Soc J 1965, 12:262-274.
76. Zhang H, Smail N, Cabral A, Rogiers P, Vincent JL: Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. Am J Respir Crit Care Med 1997, 155:1965-1971. In endotoxic dogs submitted to tamponade, norepinephrine increased liver blood flow by an increase in hepatic artery but not in portal blood flow. Norepinephrine also increased critical oxygen extraction.
77. Seelig RF, Kerr JC, Hobson RW, Machiedo GW: Prostacyclin (epoprostenol): its effects on canine splanchnic blood flow during hemorrhagic shock. Arch Surg 1981,116:428-430.
78. 1 prevents the development of multiple organ failure. J Hepatol 1994, 20:478-482.
79. Raper RF, Sibbald WJ, Hobson J, Rutledge FS: Effect of PGE1 on altered distribution of regional blood flows in hyperdynamic sepis. Chest 1991, 100:1703-1711.
80. Rasmussen I, Arvidsson D, Zak A, Haglund UH: Splanchnic and total body oxygen consumption in experimental fecal peritonitis in pigs: effects of dextran and iloprost. Circ Shock 1992, 36:299-306.
81. Starlinger M, Jakesz R, Matthews JB, Yoon C, Schiessel R: The relative importance of HCO3- and blood flow in the protection of rat gastric mucosa during shock. Gastroenterology 1981, 81:732-735.
82. Ayuse T, Revelly JP, Boitnott JK, Robotham JL: Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 1995, 78:1319-1329.
83. Fan WQ, Smolich JJ, Wild J, Yu VYH, Walker AM: Nitric oxide modulates regional blood flow differences in the fetal gastrointestinal tract. Am J Physiol 1996, 271:G598-G604.
84. Allman KG, Stoddart AP, Kennedy MM, Young JD: L-Arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia. Am J Physiol 1996, 271:H1296-H1301.
85. Boughton-Smith NK, Hucheson IR, Deaking AM, Whittle BJR, Moncada S: Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990, 191:485-488.
86. Zhang H, Rogiers P, Friedman G, Preiser JC, Spapen H, Buurman WA, Vincent JL: Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock. Arch Surg 1996, 131:767-774. Nitric oxide donor (SIN-1) administration increased mesenteric blood flow.
87. Gauthier TW, Davenpeck KL, Lefer AM: Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia reperfusion. Am J Physiol 1994, 267:G562-G568.
88. Mendez A, Casadevall M, Wachter CH, Elizalde JI, Del Rivero M, Heinemann A, Holzer P, Quintero E, Pique JM: Gastric mucosal blood flow regulation in response to different stimuli. Digest Dis Sci 1997, 42:1873-1879.
89. Walker TA, Curtis SE, King-Vanvlack CE, Chapler CK, Vallet B, Cain SM: Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs. Shock 1995, 4:415-420.
90. Pilette C, Kirstetter P, Sogni P, Cailmail S, Moreau R, Lebrec D: Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. J Gastroenterol and Hematol 1996, 11:1-6. Monomethyl-L-arginine decreased portal blood flow in cirrhotic more than in noncirrhotic rats.
91. Booke M, Hinder F, McGuire R, Traber LD, Traber DL: Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow. Shock 1996, 5:362-370.
92. Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, Metz G, Vincent JL: Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 1995, 23:1711-1721.
93. Salzman AL, Menconi MJ, Unno N, Ezzel RM, Casey DM, Gonzalez PK, Fink MP: Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BB intestinal epithelial monolayers. Am J Physiol 1995, 268:G361-G373.
94. Vollmar B, Lang G, Menger MD, Mesmer K: Hypertonic hydroxyethyl starch restores hepatic microvascular perfusion in hemorrhagic shock. Am J Physiol 1994, 266:H1927-H1934.
95. Schleiffer R, Raul F: Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischemia. Gut 1996, 39:194-198.
96. Adawi D, Kasravi FB, Molin G, Jeppsson B: Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 1997, 25:642-647.
97. Chamulitrat W, Skrepnik NV, Spitzer JJ: Endotoxin-induced oxidative stress in the rat small intestine: role of nitric oxide. Shock 1996, 5:217-222.
98. Sorells DL, Friend C, Koltuksuz U, Courcoulas A, Boyle P, Garett M, Watkins S, Rowe Ml, Ford HR: Inhibition of nitric oxide with aminoguadine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 1996, 131:1155-1163.
99. Braga M, Gianotti L, Cestari A, Vignali A, Pellegatta F, Dolci A, Di Carlo V: Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enterai formulas. Arch Surg 1996, 131:1257-1265.
100. Layland M, Mythen MG, Wang KY, Albaladejo P, Leone BJ: Measurement of gastrointestinal intramucosal pH is a poor guide to tolerable levels of anemia during isovolemic hemodilution in a canine model of coronary stenosis. Arch Surg 1997, 132:547-552.
101. Haisjackl M, Luz G, Sparr H, Germann R, Salak N, Friesenecker B, Deusch E, Meusburger S, Hasibeder W: The effects of progressive anemia on jejunal mucosal and serosal tissue oxygenation in pigs. Anesth Analg 1997, 84:538-544.
102. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269:3024-3029.
103. 2 and restored microvilus architecture.
104. Xu L, Rollwagen FM, Li Y, Pacheco ND, Pikoulis E, Leppäniemi A, Soltero R, Burris D, Malcolm D, Nielsen TB: Cellular response to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 1997, 42:32-41. Diaspirin cross-linked hemoglobin decreased mucosal damage and bacterial translocation in a rat model of hemorrhage.
105. Siegel JH, Fabian M, Smith JA, Costantino D: Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 1997, 42:199-212 Recombinant hemoglobin solution and erythrocyte administration in dogs submitted to severe hemorrhagic shock resulted in a similar survival rate but improved regional blood flows.
106. Mourelatos MG, Enzer N, Ferguson JL, Rypins EB, Burhop KE, Law WR: The effects of diaspirin cross-linked hemoglobin in sepsis. Shock 1996, 5:141-148.
107. Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHbTM) as a vasopressor in critically ill patients. Crit Care Med 1997, 25:1480-1488. Diaspirin cross-linked hemoglobin administration in 14 septic patients resulted in an increase in arterial pressure and in a nonsignificant increase in pHi.